Short report: High prevalence and imbalanced age distribution of the Plasmodium falciparum dihydrofolate reductase gene Asn108 mutation in an area of low pyrimethamine usage in Nigeria

American Journal of Tropical Medicine and Hygiene

Volumn 61, Issue 3, 1999, Pages 375-377

  Mockenhaupt, Frank P ^a   May, Jürgen ^a   Eggelte, Teunis A ^b   Thies, Frank L ^a   Ademowo, Olusegun G ^c   Bienzle, Ulrich ^a   Meyer, Christian G ^a  

^a Institut fur Tropenmedizin   (Germany)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE; PYRIMETHAMINE;

AGE DISTRIBUTION; ARTICLE; GENE AMPLIFICATION; GENE MUTATION; GENOTYPE; MALARIA; NIGERIA; NONHUMAN; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMERASE CHAIN REACTION; PREVALENCE;

PLASMODIUM FALCIPARUM;

EID: 0032841848     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1999.61.375     Document Type: Article

References (10)

1. Cowman AF, Morry MJ, Biggs BA, Cross GA, Foote SJ, 1988. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proc Nat Acad Sci USA 85: 9109-9113.
2. Peterson DS, Walliker D, Wellems TE, 1988. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc Nat Acad Sci USA 85: 9114-9118.
3. Curtis J, Duraisingh MT, Trigg JK, Mbwana H, Warhurst DC, Curtis CF, 1996. Direct evidence that asparagine at position 108 of the Plasmodium falciparum dihydrofolate reductase is involved in resistance to antifolate drugs in Tanzania. Trans R Soc Trop Med Hyg 90: 678-680.
4. Plowe CV, Djimde A, Wellems TE, Diop S, Kouriba B, Doumbo OK, 1996. Community pyrimethamine-sulfadoxine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: a model for deterring resistance. Am J Trop Med Hyg 55: 467-471.
5. Falade CO, Salako LA, Sowunmi A, Oduola AM, Larcier P, 1997. Comparative efficacy of halofantrine, chloroquine and sulfadoxine-pyrimethamine for treatment of acute uncomplicated falciparum malaria in Nigerian children. Trans R Soc Trop Med Hyg 91: 58-62.
6. Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, do Rosario VE, Thaithong S, Brown KN, 1993. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitai 61: 315-320.
7. Eggelte TA, 1990. Production of monoclonal antibodies against antimalarial drugs for use in immunoassays. Navaratnam V, Payne D, eds. The validation of chemical and immunochemical tests for antimalarials in body fluids. International Monograph Series. Penang: University Saint Malaysia, 35-63.
8. Plowe CV, Cortese JF, Djimde A, Nwanyanwu OC, Watkins WM, Winstanley PA, Estrada-Franco JG, Mollinedo RE, Avila JC, Cespedes JL, Carter D, Doumbo OK, 1997. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiology patterns of pyrimethamine-sulfadoxine use and resistance. J Infect Dis 176: 1590-1596.
9. Babiker HA, Abdel-Muhsin AMA, Ranford-Cartwright LC, Satti G, Walliker D, 1998. Characteristics of Plasmodium falciparum parasites that survive the lengthy season in eastern Sudan where malaria transmission is markedly seasonal. Am J Trop Med Hyg 59: 582-590.
10. Weidekamm E, Plozza-Nottebrock H, Forgo I, Durbach UC, 1982. Plasma concentrations of pyrimethamine and sulfadoxine and evaluation of pharmacokinetic data by computerized curve fitting. Bull World Health Organ 60: 115-122.